1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AURINIA PHARMACEUTICALS INC
Aurinia Pharmaceuticals Inc XNAS: AUPH

Aurinia Pharma Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for ...

Read More
15.89 -0.36 (-2.22%)
New 52W High in past week
680.0K
XNAS Volume

XNAS 29 Dec, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
High Financial Strength
83.3 / 100
Valuation Score
Mid Valuation
42.0 / 100
Momentum Score
Technically Moderately Bullish
67.1 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM
Analyst Price Target
17
1Yr Price target upside is 5%
6 analysts

23

S

6

W

3

O

1

T

SWOT Analysis

Aurinia Pharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..